WhizAI Pharmaceutical Marketing Analytics Features
- Real-Time Data:
With WhizAI, there’s no need to wait for data insights. Marketing teams can access information on-demand rather than wait for a data or IT team to work analysis into its schedule.
- Industry-Specific Training:
Generic AI platforms may claim to work for life sciences use cases. However, they take months of training before they can deliver relevant, accurate insight to life sciences teams. WhizAI is pre-trained for life sciences and deploys in just a few weeks.
- Natural Language Processing (NLP):
WhizAI leverages NLP, which allows the platform to understand a pharma marketing team’s question using terms, phrasing, and acronyms they’d normally use – and answers using terminology and metrics that users are accustomed to.
- Contextual Insights:
Pharmaceutical marketing analytics from WhizAI are specific to the product, market, and region the team asks about, unlike dashboards that are created to provide information to a broad range of users.
How WhizAI Works
WhizAI combines data from primary and secondary sources and quickly analyzes petabytes of data within a sub-second – and it automatically scales as data volumes grow. This gives marketers the ability to use both industry data and internal data from marketing campaign performance to optimize campaigns with minimal intervention from the data team.
WhizAI’s hybrid AI engine combines pre-trained and configurable models to provide industry-leading domain expertise. Furthermore, every time a user asks a question, asks follow-up queries, and interacts with the platform, WhizAI learns, continually refining the user’s intent and context.
Although WhizAI can be used as an advanced pharmaceutical marketing analytics solution, it doesn’t require advanced expertise in data analytics. It’s designed to make data insights accessible and consumable, taking only a few minutes of training, regardless of data science or IT expertise.
Additionally, life sciences marketing teams can use WhizAI as a standalone solution or as a complement to BI dashboards to paint a total picture of opportunities, marketing tactics and campaigns that have historically been most effective with the target audience and how well current campaigns are performing.
The Benefits of Instant Access to Pharmaceutical Marketing Analytics
Data-driven decision making:
WhizAI is as intuitive as a social media app, making it easy for marketers to build data-driven decision making into their daily workflows – and see greater productivity and improved outcomes. It’s common for a company deploying WhizAI to see 100% adoption.
Less dependence on the data team:
WhizAI is intuitive. Users can create their own dashboards and choose the visualizations they prefer in a no-code environment. Life sciences companies using WhizAI decrease dependence on their IT teams by as much as 60%.
More effective marketing:
Pharmaceutical marketing analytics confirms what’s working – and what isn’t. Insights from WhizAI allow marketers to develop a product value story from development to clinical trials and commercialization.
Insights for marketers on the move:
Marketers can embed WhizAI in the applications they use, allowing them to access data insights with just a click. Additionally, users can access pharmaceutical marketing analytics from a PC, laptop, tablet, or smartphone.
When marketing campaigns are based on data and teams have real-time access to their effectiveness, life science companies have greater visibility and more control over the success of a campaign. Marketers can elevate brands, help increase market penetration, and improve the bottom line.
To learn more about connecting your team with instant access to pharmaceutical marketing analytics, join a weekly demo to see WhizAI in action or contact us.
A New Era of Personalization: Applying Generative AI to Dynamic Customer Engagement
Webinar Series: Part 4 - Give Your Life Sciences Analytics the ExplAIn Advantage
Gartner® Market Guide 2023 for Augmented Analytics Focuses on the Impact of Generative AI and Domain-Specificity
WhizAI is recognized among representative vendors in augmented analytics but stands apart as the only platform developed for life sciences in Gartner’s Market Guide for Augmented Analytics 2023.
Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It
High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers the total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.
Gartner® Predicts Augmented Analytics Will Have a Major Impact on Life Sciences Commercial Functions
Gartner recognizes WhizAI as a Sample Vendor for Augmented Analytics, an emerging technology poised to revolutionize how commercial teams use data insights to optimize outcomes.
WhizAI Deployed as a New Field Reporting System at a Top 3 Global Pharma
Better, Faster, Smarter Decisions at Lower Cost for a Top 3 Global Pharma. A top 3 global pharmaceutical faced the following challenges with their legacy field reporting system:
WhizAI Puts Sales Reps at the Center of the Analytics Process for a Leading Specialty Pharmaceutical Company
Sales reps use WhizAI data exploration to answer questions like 'Sales trends this year by region, brand (or by city, territory, GPO, COT, IDN)?' in seconds.